In: Respiratory Research, 18 (2017), Nr. 171. pp. 1-11. ISSN 1465-993X

Preview

PDF, English Download (942kB) | Lizenz: Cardiovascular risk in patients with alpha-1-antitrypsin deficiency by Fähndrich, Sebastian ; Biertz, Frank ; Karch, Annika ; Kleibrink, Björn ; Koch, Armin ; Teschler, Helmut ; Welte, Tobias ; Kauczor, Hans-Ulrich ; Janciauskiene, Sabina ; Jörres, Rudolf A. ; Greulich, Timm ; Vogelmeier, Claus F. ; Bals, Robert underlies the terms of Creative Commons Attribution 3.0 Germany

Abstract

Background: Alpha-1-antitrypsin deficiency (AATD) is a rare inherited condition caused by mutations of the SERPINA1 gene that is associated with the development of a COPD like lung disease. The comorbidities in patients with AATD-related lung diseases are not well defined. The aim of this study was to analyze the clinical phenotype of AATD patients within the German COPD cohort study COSYCONET (“COPD and SYstemic consequences-COmorbidities NETwork”) cohort focusing on the distribution of comorbidities. Method and results: The data from 2645 COSYCONET patients, including 139 AATD patients (110 with and 29 without augmentation therapy), were analyzed by descriptive statistics and regression analyses. We found significantly lower prevalence of cardiovascular comorbidities in AATD patients as compared to non-AATD COPD patients. After correction for age, pack years, body mass index, and sex, the differences were still significant for coronary artery disease (p = 0.002) and the prevalence of peripheral artery disease as determined by an ankle-brachial-index <= 0.9 (p = 0.035). Also the distribution of other comorbidities such as bronchiectasis differed between AATD and non-deficient COPD. Conclusion: AATD is associated with a lower prevalence of cardiovascular disease, the underlying mechanisms need further investigation.